Key points
- Encoded in mitochondrial rather than nuclear DNA — unusual among signalling peptides
- One of a small set of known mitochondrial-derived peptides
- Research centres on AMPK signalling and metabolic homeostasis
- Has been described as a mitochondrial-to-nuclear signalling molecule
A peptide encoded in the wrong place
Mitochondria carry their own small genome, separate from nuclear DNA and inherited maternally. It was long assumed to encode only components of the respiratory machinery. MOTS-c is notable because it is encoded within that mitochondrial genome yet appears to act as a signalling molecule with effects well beyond the organelle.
That makes it one of a small number of identified mitochondrial-derived peptides, and the category itself is a relatively recent addition to the literature. The conceptual interest is as significant as any specific finding: it suggests mitochondria may participate in cellular signalling more directly than the conventional picture allows.
Retrograde signalling
The standard model of cellular control runs outward from the nucleus. Mitochondrial-derived peptides suggest information also travels the other way — mitochondria communicating their state to the nucleus and influencing gene expression in response.
This is described in the literature as retrograde signalling. If mitochondrial function is a determinant of metabolic health, a mechanism by which mitochondria report their status to the rest of the cell is a natural focus for research into how metabolic state is regulated.
AMPK and metabolic regulation
Most of the mechanistic work on MOTS-c concerns AMP-activated protein kinase. AMPK functions as a cellular energy sensor: it responds to the ratio of AMP to ATP and, when energy is scarce, shifts the cell towards energy production and away from energy consumption.
Research has investigated whether MOTS-c influences this pathway and, through it, glucose handling and metabolic flexibility. Studies in animal models have examined insulin sensitivity and related metabolic markers under this framing.
The exercise connection
MOTS-c attracts attention in exercise science because reported responses to exercise, and its association with metabolic adaptation, position it as a candidate mediator of some of the metabolic effects of physical activity.
This is an area where enthusiasm has outpaced evidence. Association with exercise response is not the same as mediating it, and the causal question is not settled. Research framing should be careful to distinguish the two.
Where the field stands
MOTS-c is a comparatively recent discovery and the literature is correspondingly thinner than for longer-studied compounds. Basic questions about physiological regulation and tissue distribution remain open.
For researchers, that is an opportunity and a caution in equal measure. There is genuine scope for novel contribution, and correspondingly little established groundwork to build on.
For laboratory research use only. This article summarises published research for scientific reference. It is not guidance for human or veterinary use, and nothing here describes a treatment for any condition. NexPep compounds are supplied strictly for laboratory research.